Back to Insider Trading View Full Company Profile

TECX

UNKNOWN

Tectonic Therapeutic, Inc.

CIK: 0001681087

Sell (70% confidence)

Last activity: 3 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Total Cash $253.80M

Trend Signals

CEO Buy STRONG

CEO buying activity

Feb 11, 2026

CFO Buy STRONG

CFO buying activity

Feb 10, 2026

Insider Roster (4 total, 4 active)

Insider	Buys	Sells	Net Value	Holdings
Ruddy Marcella K. Chief Medical Officer	0	2	-$331K	68,747 shares $2.13M
McNamara Peter Chief Scientific Officer	0	4	-$267K	55,500 shares $1.67M
Lochner Daniel Chief Financial Officer	1	0	$130K	32,044 shares $692K
REICIN ALISE Chief Executive Officer	2	0	$106K	127,030 shares $2.68M

Recent Transactions

SELL Ruddy Marcella K. (Chief Medical Officer)

1,000 shares @ $31.05

$31K

Apr 1, 2026

Conviction: | View SEC Filing →

SELL Ruddy Marcella K. (Chief Medical Officer)

10,000 shares @ $30.00

$300K

Mar 6, 2026

Conviction: | View SEC Filing →

SELL McNamara Peter (Chief Scientific Officer)

6,047 shares @ $30.00

$181K

Mar 6, 2026

Conviction: | View SEC Filing →

SELL McNamara Peter (Chief Scientific Officer)

215 shares @ $35.00

$8K

Mar 6, 2026

Conviction: | View SEC Filing →

SELL McNamara Peter (Chief Scientific Officer)

1,650 shares @ $25.00

$41K

Mar 4, 2026

Conviction: | View SEC Filing →

SELL McNamara Peter (Chief Scientific Officer)

1,649 shares @ $22.06

$36K

Mar 3, 2026

Conviction: | View SEC Filing →

BUY REICIN ALISE (Chief Executive Officer)

2,500 shares @ $21.10

$53K

Feb 11, 2026

Conviction: | View SEC Filing →

BUY REICIN ALISE (Chief Executive Officer)

2,500 shares @ $21.10

$53K

Feb 11, 2026

Conviction: | View SEC Filing →

BUY Lochner Daniel (Chief Financial Officer)

6,000 shares @ $21.61

$130K

Feb 10, 2026

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.